Back to 
Hood River Capital Management LLC
Hood River Capital Management LLC
CRVS
2 quarters
Position history for Hood River Capital Management LLC's holdings in Corvus Pharmaceuticals, Inc.
Yes. Hood River Capital Management holds 1,571,805 shares of CRVS (Corvus Pharmaceuticals), worth $23.5M, as of its Q2 2026 13F filing. It increased the position by 236,696 shares (+17.7%) from Q1 2026. Hood River Capital Management has held CRVS since Q1 2026, across 2 quarterly 13F filings. CRVS is 0.2% of Hood River Capital Management's reported 13F portfolio.
Current Value
$23.5M
Current Shares
1.6M
Total Value Change
+$4M
Total Shares Change
+236,696
Quarter-by-Quarter History
Other major holders of CRVS: BlackRock, Inc., State Street Corp., T. Rowe Price Associates, Inc.